4-Oxo-3,4-dihydro-benzo[d][1,2,3]triazine-8-carboxylic acid amide

ID: ALA37240

PubChem CID: 135518053

Max Phase: Preclinical

Molecular Formula: C8H6N4O2

Molecular Weight: 190.16

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1cccc2c(O)nnnc12

Standard InChI:  InChI=1S/C8H6N4O2/c9-7(13)4-2-1-3-5-6(4)10-12-11-8(5)14/h1-3H,(H2,9,13)(H,10,11,14)

Standard InChI Key:  CFFIFXRBQJCGER-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
    6.8417   -6.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8417   -7.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2750   -6.3667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1292   -5.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5542   -5.9542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5542   -7.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2750   -7.2000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0875   -5.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5542   -8.4375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7792   -4.6917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3500   -4.7625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1292   -7.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4167   -6.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4167   -7.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  5  2  0
  4  1  1  0
  5  1  1  0
  6  2  1  0
  7  3  1  0
  8  4  1  0
  9  6  1  0
 10  8  2  0
 11  8  1  0
 12  2  1  0
 13  4  2  0
 14 13  1  0
  6  7  2  0
 14 12  2  0
M  END

Alternative Forms

  1. Parent:

    ALA37240

    ---

Associated Targets(non-human)

TLX-5 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 190.16Molecular Weight (Monoisotopic): 190.0491AlogP: -0.17#Rotatable Bonds: 1
Polar Surface Area: 101.99Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.77CX Basic pKa: CX LogP: -0.39CX LogD: -0.41
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.65Np Likeness Score: -0.86

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]

Source